Vanguard Group Inc Recursion Pharmaceuticals, Inc. Transaction History

Vanguard Group Inc

  • $5.57 Trillion
  • Q4 2024

A detailed history of Vanguard Group Inc transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 34,009,994 shares of RXRX stock, worth $352 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
34,009,994
Previous 24,272,798 40.12%
Holding current value
$352 Million
Previous $160 Million 43.73%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
BUY
$5.7 - $8.27 $55.5 Million - $80.5 Million
9,737,196 Added 40.12%
34,009,994 $230 Million
Q3 2024

Nov 13, 2024
BUY
$5.92 - $8.6 $16.1 Million - $23.4 Million
2,716,252 Added 12.6%
24,272,798 $160 Million
Q2 2024

Aug 13, 2024
BUY
$7.35 - $10.05 $40.7 Million - $55.7 Million
5,541,782 Added 34.6%
21,556,546 $162 Million
Q1 2024

May 10, 2024
BUY
$9.13 - $15.52 $3.19 Million - $5.43 Million
349,554 Added 2.23%
16,014,764 $160 Million
Q4 2023

Feb 14, 2024
BUY
$5.09 - $10.79 $806,133 - $1.71 Million
158,376 Added 1.02%
15,665,210 $154 Million
Q3 2023

Nov 14, 2023
BUY
$6.59 - $15.86 $28 Million - $67.4 Million
4,247,002 Added 37.72%
15,506,834 $119 Million
Q2 2023

Aug 14, 2023
BUY
$4.56 - $9.94 $1.49 Million - $3.24 Million
326,248 Added 2.98%
11,259,832 $84.1 Million
Q1 2023

May 15, 2023
BUY
$6.42 - $9.64 $5.63 Million - $8.45 Million
876,221 Added 8.71%
10,933,584 $72.9 Million
Q4 2022

Feb 10, 2023
BUY
$7.16 - $12.7 $12 Million - $21.3 Million
1,676,377 Added 20.0%
10,057,363 $77.5 Million
Q3 2022

Nov 14, 2022
BUY
$7.83 - $13.6 $10.9 Million - $19 Million
1,393,519 Added 19.94%
8,380,986 $89.2 Million
Q2 2022

Aug 12, 2022
BUY
$5.04 - $9.26 $1.9 Million - $3.48 Million
376,090 Added 5.69%
6,987,467 $56.9 Million
Q1 2022

May 13, 2022
BUY
$6.16 - $18.03 $3.06 Million - $8.97 Million
497,504 Added 8.14%
6,611,377 $47.3 Million
Q4 2021

Feb 14, 2022
BUY
$16.14 - $21.86 $54.9 Million - $74.4 Million
3,401,893 Added 125.44%
6,113,873 $105 Million
Q3 2021

Nov 12, 2021
BUY
$19.03 - $41.33 $549,453 - $1.19 Million
28,873 Added 1.08%
2,711,980 $62.4 Million
Q2 2021

Aug 13, 2021
BUY
$18.0 - $37.42 $48.3 Million - $100 Million
2,683,107 New
2,683,107 $97.9 Million

Others Institutions Holding RXRX

# of Institutions
339
Shares Held
284M
Call Options Held
2.83M
Put Options Held
3.64M
View Full List

About RECURSION PHARMACEUTICALS, INC.

RXRX Quotes by TradingView
  • Ticker RXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 180,480,000
  • Market Cap $1.87B
  • Description
  • Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...
More about RXRX
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email